Rituximab® and high dose methylprednisolone (HDMP) as a first line treatment for patients with chronic lymphocytic leukemia

被引：0
|
作者：
Castro, JE
Bole, JE
Prada, CE
Loria, O
Kipps, TJ
机构：
[1] Univ Calif San Diego, John & Rebecca Moores Canc Ctr, La Jolla, CA 92093 USA
[2] Chron Lymphocyt Leukemia Res Consortium, San Diego, CA USA
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2969
引用
收藏
页码：833A / 833A
页数：1
相关论文
共 50 条
  • [41] Fludarabine, cyclophosphamide and rituximab (FCR) in front line treatment of patients with chronic lymphocytic leukemia (CLL)
    Grifi, Fatiha
    Bougherira, Soraya
    Djenouni, Amel
    LEUKEMIA & LYMPHOMA, 2017, 58 : 94 - 94
  • [42] RITUXIMAB IN COMBINATION WITH HIGH-DOSE DEXAMETHASONE: AN EFFECTIVE TREATMENT OPTION FOR PATIENTS WITH RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA
    Simkovic, M.
    Panovska, A.
    Belada, D.
    Hrudkova, M.
    Brychtova, Y.
    Mayer, J.
    Smolej, L.
    Doubek, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 326 - 326
  • [43] Outcomes of Patients With Chronic Lymphocytic Leukemia Treated With First-Line Idelalisib Plus Rituximab After Cessation of Treatment for Toxicity
    Thompson, Philip A.
    Stingo, Francesco
    Keating, Michael J.
    Ferrajoli, Alessandra
    Burger, Jan A.
    Wierda, William G.
    Kadia, Tapan M.
    O'Brien, Susan M.
    CANCER, 2016, 122 (16) : 2505 - 2511
  • [44] Rituximab in addition to methylprednisolone in pretreated elderly or unfit patients with B-chronic lymphocytic leukemia
    Pileckyte, Regina
    Klimiene, Indre
    Valceckiene, Vilma
    Sejoniene, Jurgita
    Viselgaite, Laura
    Zvirblis, Tadas
    Griskevicius, Laimonas
    LEUKEMIA & LYMPHOMA, 2015, 56 : 154 - 155
  • [45] Treatment with rituximab of chronic lymphocytic leukemia in pregnancy
    Garcia, Rafael Lluch
    Hernandez-Lorente, Eva
    Corella, Paula Carcel
    MEDICINA CLINICA, 2021, 156 (10): : 525 - 525
  • [46] Outcomes of first line chemotherapy in patients with chronic lymphocytic leukemia
    Nazir, Adil
    Fawad
    Ali, Sheeraz
    Badar, Farhana
    Siddique, Neelam
    Hameed, Abdul
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2016, 32 (05) : 1213 - 1217
  • [47] The combination of venetoclax and rituximab for the treatment of patients with recurrent chronic lymphocytic leukemia
    Vitale, Candida
    Ferrajoli, Alessandra
    EXPERT REVIEW OF HEMATOLOGY, 2020, 13 (08) : 885 - 894
  • [48] OBINUTUZUMAB IN COMBINATION WITH CHLORAMBUCIL IN THE FIRST LINE OF TREATMENT OF ELDERLY PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA
    Markova, E. E.
    Nikitin, E. A.
    Dmitrieva, E. A.
    Mayorova, S. Yu
    Kochkareva, Yu B.
    Naumova, E., V
    Lugovskaya, S. A.
    Pochtar, M. E.
    Petrenko, A. A.
    Kislova, M., I
    Biderman, B., V
    Sudarikov, A. B.
    Obukhova, T. N.
    Ptushkin, V. V.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2022, 67 (04): : 478 - 490
  • [49] Cost burden of first-line treatment failure in patients with chronic lymphocytic leukemia
    Lafeuille, Marie-Helene
    Wang, Song
    Lefebvre, Patrick
    Senbetta, Mekre
    Emond, Bruno
    Romdhani, Hela
    LEUKEMIA & LYMPHOMA, 2017, 58 : 99 - 100
  • [50] Chemoimmunotherapy With Low-Dose Fludarabine and Cyclophosphamide and High Dose Rituximab in Previously Untreated Patients With Chronic Lymphocytic Leukemia
    Foon, Kenneth A.
    Boyiadzis, Michael
    Land, Stephanie R.
    Marks, Stanley
    Raptis, Anastasios
    Pietragallo, Louis
    Meisner, Dennis
    Laman, Andrew
    Sulecki, Mathew
    Butchko, Allyson
    Schaefer, Patricia
    Lenzer, Diana
    Tarhini, Ahmad
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (04) : 498 - 503
12345